# Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study

> **NCT03597815** · — · UNKNOWN · sponsor: **Uptown Eye Specialists** · enrollment: 150 (estimated)

## Conditions studied

- Diabetic Macular Edema
- Sleep Apnea
- Non Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** Aflibercept 40 MG/ML [Eylea]
- **DIAGNOSTIC_TEST:** OSA diagnostic test - overnight sleep study
- **DEVICE:** CPAP therapy for OSA positive patients

## Key facts

- **NCT ID:** NCT03597815
- **Lead sponsor:** Uptown Eye Specialists
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03597815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03597815, "Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03597815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*